+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Multiple Sclerosis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • PDF Icon

    Report

  • 97 Pages
  • February 2024
  • Region: Global
  • Prof Research
  • ID: 5729902
Description Jump to:

Quick Summary:

Dive deep into the data-driven insights of the global Multiple Sclerosis Drugs market and navigate your business to lucrative opportunities with our in-depth market research report. This comprehensive study carries out an extensive analysis from 2018 all the way up to the forecast data that stretches beyond the horizon, up to 2028.

The meticulous report evaluates regional demand and supply trends, pricing behavior, key players, and competitor market shares for the North America, South America, Asia & Pacific, Europe, and MEA regions. A broad list of market areas including the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil, among others, have been analyzed. This report also provides a detailed company profile, main business information, SWOT Analysis, sales volume, revenue, price, and gross margin of global key players of Multiple Sclerosis Drug, including behemoths such as Sanofi, Bayer, Teva Pharmaceuticals, Novartis, EMD Serono, Genentech, and Biogen.

This report describes the global market size of Multiple Sclerosis Drug from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Multiple Sclerosis Drug as well as some small players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Types Segment

  • Beta interferons
  • Glatiramer
  • Cladribine
  • Dimethyl fumarate
  • Diroximel fumarate
  • Fingolimod
  • Monomethyl fumarate
  • Ofatumumab
  • Ozanimod
  • Ponesimod
  • Siponimod
  • Others

Companies Covered

  • Biogen Inc.
  • Bristol Myers Squibb Co.
  • EMD Serono Inc.
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • Sanofi
  • Teva Pharmaceuticals Industries LTD
  • Roche
  • Bayer
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Multiple Sclerosis Drug Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Multiple Sclerosis Drug Market in North America (2019-2029)
8.1 Multiple Sclerosis Drug Market Size
8.2 Multiple Sclerosis Drug Market by End Use
8.3 Competition by Players/Suppliers
8.4 Multiple Sclerosis Drug Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Multiple Sclerosis Drug Market in South America (2019-2029)
9.1 Multiple Sclerosis Drug Market Size
9.2 Multiple Sclerosis Drug Market by End Use
9.3 Competition by Players/Suppliers
9.4 Multiple Sclerosis Drug Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Multiple Sclerosis Drug Market in Asia & Pacific (2019-2029)
10.1 Multiple Sclerosis Drug Market Size
10.2 Multiple Sclerosis Drug Market by End Use
10.3 Competition by Players/Suppliers
10.4 Multiple Sclerosis Drug Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Multiple Sclerosis Drug Market in Europe (2019-2029)
11.1 Multiple Sclerosis Drug Market Size
11.2 Multiple Sclerosis Drug Market by End Use
11.3 Competition by Players/Suppliers
11.4 Multiple Sclerosis Drug Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Multiple Sclerosis Drug Market in MEA (2019-2029)
12.1 Multiple Sclerosis Drug Market Size
12.2 Multiple Sclerosis Drug Market by End Use
12.3 Competition by Players/Suppliers
12.4 Multiple Sclerosis Drug Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Multiple Sclerosis Drug Market (2019-2024)
13.1 Multiple Sclerosis Drug Market Size
13.2 Multiple Sclerosis Drug Market by End Use
13.3 Competition by Players/Suppliers
13.4 Multiple Sclerosis Drug Market Size by Type
Chapter 14 Global Multiple Sclerosis Drug Market Forecast (2024-2029)
14.1 Multiple Sclerosis Drug Market Size Forecast
14.2 Multiple Sclerosis Drug Application Forecast
14.3 Competition by Players/Suppliers
14.4 Multiple Sclerosis Drug Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Biogen Inc.
15.1.1 Company Profile
15.1.2 Main Business and Multiple Sclerosis Drug Information
15.1.3 SWOT Analysis of Biogen Inc.
215.1.4 Biogen Inc. Multiple Sclerosis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.2 Bristol Myers Squibb Co.
15.2.1 Company Profile
15.2.2 Main Business and Multiple Sclerosis Drug Information
15.2.3 SWOT Analysis of Bristol Myers Squibb Co.
215.2.4 Bristol Myers Squibb Co. Multiple Sclerosis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.3 EMD Serono Inc.
15.3.1 Company Profile
15.3.2 Main Business and Multiple Sclerosis Drug Information
15.3.3 SWOT Analysis of EMD Serono Inc.
215.3.4 EMD Serono Inc. Multiple Sclerosis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.4 Johnson & Johnson
15.4.1 Company Profile
15.4.2 Main Business and Multiple Sclerosis Drug Information
15.4.3 SWOT Analysis of Johnson & Johnson
215.4.4 Johnson & Johnson Multiple Sclerosis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.5 Merck & Co. Inc.
15.5.1 Company Profile
15.5.2 Main Business and Multiple Sclerosis Drug Information
15.5.3 SWOT Analysis of Merck & Co. Inc.
215.5.4 Merck & Co. Inc. Multiple Sclerosis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.6 Novartis AG
15.6.1 Company Profile
15.6.2 Main Business and Multiple Sclerosis Drug Information
15.6.3 SWOT Analysis of Novartis AG
215.6.4 Novartis AG Multiple Sclerosis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.7 Sanofi
15.7.1 Company Profile
15.7.2 Main Business and Multiple Sclerosis Drug Information
15.7.3 SWOT Analysis of Sanofi
215.7.4 Sanofi Multiple Sclerosis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.8 Teva Pharmaceuticals Industries LTD
15.8.1 Company Profile
15.8.2 Main Business and Multiple Sclerosis Drug Information
15.8.3 SWOT Analysis of Teva Pharmaceuticals Industries LTD
215.8.4 Teva Pharmaceuticals Industries LTD Multiple Sclerosis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.9 Roche
15.9.1 Company Profile
15.9.2 Main Business and Multiple Sclerosis Drug Information
15.9.3 SWOT Analysis of Roche
215.9.4 Roche Multiple Sclerosis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.10 Bayer
15.10.1 Company Profile
15.10.2 Main Business and Multiple Sclerosis Drug Information
15.10.3 SWOT Analysis of Bayer
215.10.4 Bayer Multiple Sclerosis Drug Revenue, Gross Margin and Market Share (2019-2024)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Multiple Sclerosis Drug Report
Table Data Sources of Multiple Sclerosis Drug Report
Table Major Assumptions of Multiple Sclerosis Drug Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Multiple Sclerosis Drug Picture
Table Multiple Sclerosis Drug Classification
Table Multiple Sclerosis Drug Applications
Table Drivers of Multiple Sclerosis Drug Market
Table Restraints of Multiple Sclerosis Drug Market
Table Opportunities of Multiple Sclerosis Drug Market
Table Threats of Multiple Sclerosis Drug Market
Table COVID-19 Impact For Multiple Sclerosis Drug Market
Table Raw Materials Suppliers
Table Different Production Methods of Multiple Sclerosis Drug
Table Cost Structure Analysis of Multiple Sclerosis Drug
Table Key End Users
Table Latest News of Multiple Sclerosis Drug Market
Table Merger and Acquisition
Table Planned/Future Project of Multiple Sclerosis Drug Market
Table Policy of Multiple Sclerosis Drug Market
Table 2019-2029 North America Multiple Sclerosis Drug Market Size
Figure 2019-2029 North America Multiple Sclerosis Drug Market Size and CAGR
Table 2019-2029 North America Multiple Sclerosis Drug Market Size by Application
Table 2019-2024 North America Multiple Sclerosis Drug Key Players Revenue
Table 2019-2024 North America Multiple Sclerosis Drug Key Players Market Share
Table 2019-2029 North America Multiple Sclerosis Drug Market Size by Type
Table 2019-2029 United States Multiple Sclerosis Drug Market Size
Table 2019-2029 Canada Multiple Sclerosis Drug Market Size
Table 2019-2029 Mexico Multiple Sclerosis Drug Market Size
Table 2019-2029 South America Multiple Sclerosis Drug Market Size
Figure 2019-2029 South America Multiple Sclerosis Drug Market Size and CAGR
Table 2019-2029 South America Multiple Sclerosis Drug Market Size by Application
Table 2019-2024 South America Multiple Sclerosis Drug Key Players Revenue
Table 2019-2024 South America Multiple Sclerosis Drug Key Players Market Share
Table 2019-2029 South America Multiple Sclerosis Drug Market Size by Type
Table 2019-2029 Brazil Multiple Sclerosis Drug Market Size
Table 2019-2029 Argentina Multiple Sclerosis Drug Market Size
Table 2019-2029 Chile Multiple Sclerosis Drug Market Size
Table 2019-2029 Peru Multiple Sclerosis Drug Market Size
Table 2019-2029 Asia & Pacific Multiple Sclerosis Drug Market Size
Figure 2019-2029 Asia & Pacific Multiple Sclerosis Drug Market Size and CAGR
Table 2019-2029 Asia & Pacific Multiple Sclerosis Drug Market Size by Application
Table 2019-2024 Asia & Pacific Multiple Sclerosis Drug Key Players Revenue
Table 2019-2024 Asia & Pacific Multiple Sclerosis Drug Key Players Market Share
Table 2019-2029 Asia & Pacific Multiple Sclerosis Drug Market Size by Type
Table 2019-2029 China Multiple Sclerosis Drug Market Size
Table 2019-2029 India Multiple Sclerosis Drug Market Size
Table 2019-2029 Japan Multiple Sclerosis Drug Market Size
Table 2019-2029 South Korea Multiple Sclerosis Drug Market Size
Table 2019-2029 Southeast Asia Multiple Sclerosis Drug Market Size
Table 2019-2029 Australia Multiple Sclerosis Drug Market Size
Table 2019-2029 Europe Multiple Sclerosis Drug Market Size
Figure 2019-2029 Europe Multiple Sclerosis Drug Market Size and CAGR
Table 2019-2029 Europe Multiple Sclerosis Drug Market Size by Application
Table 2019-2024 Europe Multiple Sclerosis Drug Key Players Revenue
Table 2019-2024 Europe Multiple Sclerosis Drug Key Players Market Share
Table 2019-2029 Europe Multiple Sclerosis Drug Market Size by Type
Table 2019-2029 Germany Multiple Sclerosis Drug Market Size
Table 2019-2029 France Multiple Sclerosis Drug Market Size
Table 2019-2029 United Kingdom Multiple Sclerosis Drug Market Size
Table 2019-2029 Italy Multiple Sclerosis Drug Market Size
Table 2019-2029 Spain Multiple Sclerosis Drug Market Size
Table 2019-2029 Belgium Multiple Sclerosis Drug Market Size
Table 2019-2029 Netherlands Multiple Sclerosis Drug Market Size
Table 2019-2029 Austria Multiple Sclerosis Drug Market Size
Table 2019-2029 Poland Multiple Sclerosis Drug Market Size
Table 2019-2029 Russia Multiple Sclerosis Drug Market Size
Table 2019-2029 MEA Multiple Sclerosis Drug Market Size
Figure 2019-2029 MEA Multiple Sclerosis Drug Market Size and CAGR
Table 2019-2029 MEA Multiple Sclerosis Drug Market Size by Application
Table 2019-2024 MEA Multiple Sclerosis Drug Key Players Revenue
Table 2019-2024 MEA Multiple Sclerosis Drug Key Players Market Share
Table 2019-2029 MEA Multiple Sclerosis Drug Market Size by Type
Table 2019-2029 Egypt Multiple Sclerosis Drug Market Size
Table 2019-2029 Israel Multiple Sclerosis Drug Market Size
Table 2019-2029 South Africa Multiple Sclerosis Drug Market Size
Table 2019-2029 Gulf Cooperation Council Countries Multiple Sclerosis Drug Market Size
Table 2019-2029 Turkey Multiple Sclerosis Drug Market Size
Table 2019-2024 Global Multiple Sclerosis Drug Market Size by Region
Table 2019-2024 Global Multiple Sclerosis Drug Market Size Share by Region
Table 2019-2024 Global Multiple Sclerosis Drug Market Size by Application
Table 2019-2024 Global Multiple Sclerosis Drug Market Share by Application
Table 2019-2024 Global Multiple Sclerosis Drug Key Vendors Revenue
Figure 2019-2024 Global Multiple Sclerosis Drug Market Size and Growth Rate
Table 2019-2024 Global Multiple Sclerosis Drug Key Vendors Market Share
Table 2019-2024 Global Multiple Sclerosis Drug Market Size by Type
Table 2019-2024 Global Multiple Sclerosis Drug Market Share by Type
Table 2024-2029 Global Multiple Sclerosis Drug Market Size by Region
Table 2024-2029 Global Multiple Sclerosis Drug Market Size Share by Region
Table 2024-2029 Global Multiple Sclerosis Drug Market Size by Application
Table 2024-2029 Global Multiple Sclerosis Drug Market Share by Application
Table 2024-2029 Global Multiple Sclerosis Drug Key Vendors Revenue
Figure 2024-2029 Global Multiple Sclerosis Drug Market Size and Growth Rate
Table 2024-2029 Global Multiple Sclerosis Drug Key Vendors Market Share
Table 2024-2029 Global Multiple Sclerosis Drug Market Size by Type
Table 2024-2029 Multiple Sclerosis Drug Global Market Share by Type

Companies Mentioned

  • Biogen Inc.
  • Bristol Myers Squibb Co.
  • EMD Serono Inc.
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • Sanofi
  • Teva Pharmaceuticals Industries LTD
  • Roche
  • Bayer

Methodology

Loading
LOADING...

Related Topics

Related Reports

Multiple Sclerosis Drugs Global Market Report 2024 - Product Image

Multiple Sclerosis Drugs Global Market Report 2024

  • Report
  • 250 Pages
  • Global
From
Multiple Sclerosis Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019-2029 - Product Image

Multiple Sclerosis Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019-2029

  • Report
  • 112 Pages
  • Global
From
Primary Progressive Multiple Sclerosis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024-2032 - Product Image

Primary Progressive Multiple Sclerosis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024-2032

  • Report
  • 115 Pages
  • Global
From
Multiple Sclerosis Drugs Market Analysis & Forecast to 2024-2034 - Product Image

Multiple Sclerosis Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Multiple Sclerosis Market by Treatment Modality, Application - Global Forecast 2025-2030 - Product Image

Multiple Sclerosis Market by Treatment Modality, Application - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.